Executive vice president of sustainability and Corporate Affairs Monsanto faced with a difficult situation, which could dramatically change the company's business. Ten years ago, the company has introduced in India through a joint venture, the first in the seed cotton biotechnology trait. This trait is protected cotton crops from potentially devastating pests, reducing the need for pesticides and increase yields. Subsequently, three of the Indian state government imposed a price ceiling on these biotech seeds. In addition, in 2010, the company faces competition from more than 40 Indian seed companies that offer similar or competing biotech cotton seeds. In addition, the Federal Ministry canceled the last regulatory approval for a second, indigenously developed biotech crops, eggplant (aubergine). As the developer of innovative technologies, such as Monsanto to deal with unpredictable regulatory approval process in an increasingly competitive market? Looking ahead, the two new in-the-seed trait technologies are considering the Indian farmers. Assuming Monsanto, and if so, how? In general, what should be a long-term view of the company in this promising market? "Hide
by Robert Klassen, Ramasastry Chandrasekhar Source: Richard Ivey School of Business Foundation 18 pages. Publication Date: September 6, 2012. Prod. #: W12183-PDF-ENG
Related Case Solutions & Analyses:
Mountain Equipment Co-op: The Private Label Strategy
Canada Wide Savings Loan and Trust Company
Pleasant Popcorn Processing Co.:The Popcorn Predicament
Mafiaboy
Blue Orb: Company in Transition
Finning International: Moving into Plant Hire
Grocery Gateway.com
Monforte Dairy
The Totalline Company
Saxon Financial
